dicloxacillin has been researched along with clavulanic acid in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
| Forsgren, A; Renneberg, J | 1 |
| Finegold, SM; Goldstein, EJ; Murray, PM; Reinhardt, JF | 1 |
| Jimenez-Valera, M; Ramos-Cormenzana, A; Ruiz-Bravo, A | 1 |
| Findley, A; Johnstone, PA; Miller, SR; Mondry, T; Reed, JS | 1 |
1 review(s) available for dicloxacillin and clavulanic acid
| Article | Year |
|---|---|
Delayed cellulitis associated with conservative therapy for breast cancer.
Topics: Aged; Amoxicillin; Azithromycin; Breast Diseases; Breast Neoplasms; Cellulitis; Clavulanic Acid; Combined Modality Therapy; Dicloxacillin; Drug Therapy, Combination; Female; Humans; Lymph Node Excision; Mastectomy, Segmental; Middle Aged; Postoperative Complications; Radiotherapy Dosage | 1998 |
1 trial(s) available for dicloxacillin and clavulanic acid
| Article | Year |
|---|---|
Outpatient therapy of bite wounds. Demographic data, bacteriology, and a prospective, randomized trial of amoxicillin/clavulanic acid versus penicillin +/- dicloxacillin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Bacteria; Bites and Stings; Bites, Human; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Dicloxacillin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Penicillin V; Prospective Studies; Random Allocation; Wound Infection | 1987 |
6 other study(ies) available for dicloxacillin and clavulanic acid
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
The activity of isoxazolyl penicillins in experimental staphylococcal infection.
Topics: Animals; Clavulanic Acid; Clavulanic Acids; Cloxacillin; Dicloxacillin; Drug Therapy, Combination; Female; Floxacillin; Half-Life; Hydrogen-Ion Concentration; Methicillin; Mice; Mice, Inbred BALB C; Oxacillin; Protein Binding; Staphylococcal Infections; Staphylococcus aureus | 1989 |
Synergistic effects of dicloxacillin or clavulanic acid in combination with penicillin G or cephalothin against Yersinia enterocolitica.
Topics: beta-Lactamase Inhibitors; Cephalosporins; Cephalothin; Clavulanic Acid; Clavulanic Acids; Dicloxacillin; Drug Synergism; Microbial Sensitivity Tests; Penicillin G; Yersinia enterocolitica | 1986 |